Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Journal of Clinical Medicine
|
July 21, 2019
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes
Nicolas Vuilleumier, Sabrina Pagano, Christophe Combescure, et al.
Atherosclerosis
|
July 24, 2018
Prognostic value of pulse pressure after an acute coronary syndrome
Brahim Harbaoui, David Nanchen, Pierre Lantelme, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 10, 2025
Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease prevention
Steven H J Hageman, Stephen Kaptoge, Mari N Gynnild, et al.
Heart (British Cardiac Society)
|
March 22, 2015
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland
Roland Klingenberg, Dik Heg, Lorenz Räber, et al.
American Heart Journal
|
January 29, 2022
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial
Roland Klingenberg, Barbara E Stähli, Dik Heg, et al.
JACC. Cardiovascular Interventions
|
July 25, 2015
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study
Lorenz Räber, Roland Klingenberg, Dik Heg, et al.
European Journal of Preventive Cardiology
|
October 23, 2021
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology
Suleman Aktaa, Baris Gencer, Elena Arbelo, et al.
European Heart Journal
|
November 21, 2017
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes
Roland Klingenberg, Soheila Aghlmandi, Christoph Liebetrau, et al.
Journal of the American College of Cardiology
|
September 1, 2022
Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction
Barbara E Stähli, Roland Klingenberg, Dik Heg, et al.
Revista Espanola De Cardiologia (English Ed.)
|
May 7, 2022
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L J Visseren, François Mach, Yvo M Smulders, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Journal of Clinical Medicine
|
July 21, 2019
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes
Nicolas Vuilleumier, Sabrina Pagano, Christophe Combescure, et al.
Atherosclerosis
|
July 24, 2018
Prognostic value of pulse pressure after an acute coronary syndrome
Brahim Harbaoui, David Nanchen, Pierre Lantelme, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 10, 2025
Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease prevention
Steven H J Hageman, Stephen Kaptoge, Mari N Gynnild, et al.
Heart (British Cardiac Society)
|
March 22, 2015
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland
Roland Klingenberg, Dik Heg, Lorenz Räber, et al.
American Heart Journal
|
January 29, 2022
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial
Roland Klingenberg, Barbara E Stähli, Dik Heg, et al.
JACC. Cardiovascular Interventions
|
July 25, 2015
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study
Lorenz Räber, Roland Klingenberg, Dik Heg, et al.
European Journal of Preventive Cardiology
|
October 23, 2021
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology
Suleman Aktaa, Baris Gencer, Elena Arbelo, et al.
European Heart Journal
|
November 21, 2017
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes
Roland Klingenberg, Soheila Aghlmandi, Christoph Liebetrau, et al.
Journal of the American College of Cardiology
|
September 1, 2022
Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction
Barbara E Stähli, Roland Klingenberg, Dik Heg, et al.
Revista Espanola De Cardiologia (English Ed.)
|
May 7, 2022
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L J Visseren, François Mach, Yvo M Smulders, et al.
Page
of 10